Kalytera Announces Share Issuance for January Invoices under Payments Agreements with Salzman Group Cannabis Investing News
Lexaria Bioscience Comments on FDA Statement on Novel Nicotine Replacement Therapies Cannabis Investing News
TYME Receives FDA Guidance on Pivotal Trial for SM-88 in Treatment for Advanced Pancreatic Cancer Biotech Investing
Eyenovia Announces Confirmatory Results from Second MicroStat Phase III Registration Study for Mydriasis Biotech Investing
Hemostemix Announces UC Davis Health Added as a Trial Site for Phase II Clinical Trial Biotech Investing
Life Science Big News Roundup: Cardiovascular Performance Improvements Discovered in Lexaria’s TurboCBD(TM) Capsules Clinical Trail; NanoSphere Signs Definitive Licensing Agreement in Oregon; Biocure Signs MOU with Government of Uzbekistan and Gold-Dream LLC to Build Biosimilars Manufacturing Plant; Life Science Investing
